Evidence map›Paper›PMID 16984137›Full record

ArticleBioconjugate chemistry

Synthesis of potent inhibitors of anthrax toxin based on poly-L-glutamic acid.

Amit Joshi, Arundhati Saraph, Vincent Poon, Jeremy Mogridge, Ravi S Kane

Abstract read
In one paragraph

Article in Bioconjugate chemistry. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Polymeric drugs: Advances in the development of pharmacologically active polymers.Journal of controlled release : official journal of the Controlled Release Society · 2015
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Multivalent Inhibitors of Channel-Forming Bacterial Toxins.Current topics in microbiology and immunology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Amit JoshiThe Howard P. Isermann Department of Chemical and Biological Engineering, Rensselaer Polytechnic Institute, Troy, New York 12180, USA.
Arundhati Saraph
Vincent Poon
Jeremy Mogridge
Ravi S Kane

Funding

Development and testing of polyvalent anthrax toxin inhibitorsU01AI056546 · NIAID · UNIVERSITY OF TORONTO · PI MOGRIDGE, JEREMY S · 2003 to 2012
$11.4M
NIAID NIH HHS U01 AI056546
6 · The paper itself

Abstract

We report the synthesis of biodegradable polyvalent inhibitors of anthrax toxin based on poly-L-glutamic acid (PLGA). These biocompatible polyvalent inhibitors are at least 4 orders of magnitude more potent than the corresponding monovalent peptides in vitro and are comparable in potency to polyacrylamide-based inhibitors of anthrax toxin assembly. We have elucidated the influence of peptide density on inhibitory potency and demonstrated that these inhibitory potencies are limited by kinetics, with even higher activities seen when the inhibitors are preincubated with the heptameric receptor-binding subunit of anthrax toxin prior to exposure to cells. These polyvalent inhibitors are also effective at neutralizing anthrax toxin in vivo and represent attractive leads for designing biocompatible anthrax therapeutics.

Indexed as

Absorbable ImplantsAnimalsAntigens, BacterialBacterial ToxinsCell LineGlutamic AcidMacrophagesMiceMolecular StructureMolecular WeightPeptidesPolymersRatsRats, Inbred F344anthrax toxinAntigens, BacterialBacterial ToxinsGlutamic AcidPeptidesPolymers

Identifiers

PMID16984137
PMCPMC2698798

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.